NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $42,000 | -77.2% | 75,916 | -24.0% | 0.00% | -100.0% |
Q4 2018 | $184,000 | -6.6% | 99,831 | -5.0% | 0.00% | 0.0% |
Q3 2018 | $197,000 | +42.8% | 105,031 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $138,000 | -35.5% | 103,197 | +1.5% | 0.00% | 0.0% |
Q1 2018 | $214,000 | +65.9% | 101,697 | -2.4% | 0.00% | 0.0% |
Q4 2017 | $129,000 | +14.2% | 104,197 | +5.0% | 0.00% | 0.0% |
Q3 2017 | $113,000 | +9.7% | 99,197 | +10.6% | 0.00% | 0.0% |
Q2 2017 | $103,000 | +33.8% | 89,697 | +49.8% | 0.00% | 0.0% |
Q1 2017 | $77,000 | +2.7% | 59,897 | +0.3% | 0.00% | 0.0% |
Q4 2016 | $75,000 | -51.6% | 59,697 | -19.9% | 0.00% | 0.0% |
Q3 2016 | $155,000 | -38.5% | 74,497 | +114.7% | 0.00% | -50.0% |
Q2 2016 | $252,000 | +350.0% | 34,699 | +221.2% | 0.00% | +100.0% |
Q1 2016 | $56,000 | – | 10,802 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |